First-in-human study evaluates UB-312 in healthy subjects and patients with Parkinson's disease Sep. 19, 2019
Antisense Therapeutics reports preliminary phase II data on ATL-1102 in Duchenne muscular dystrophy Sep. 18, 2019
Life Molecular Imaging opens enrollment for phase II trial of next-generation tau PET tracer PI-2620 Sep. 17, 2019
RSS